These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18671706)

  • 21. [Splenic lymphoma with circulating hairy lymphocytes lymphoma. Clinical cytological study of 4 patients].
    Jiménez S; Molero T; Santana C; Mataix R; Guerra L; Florensa L; Woessner S; Malcorra JJ
    Sangre (Barc); 1995 Dec; 40(6):453-7. PubMed ID: 8850227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More than a third of non-gastric malt lymphomas are disseminated at diagnosis: a single center survey.
    Sretenovic M; Colovic M; Jankovic G; Suvajdzic N; Mihaljevic B; Colovic N; Todorovic M; Atkinson HD
    Eur J Haematol; 2009 May; 82(5):373-80. PubMed ID: 19141118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
    Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
    Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma.
    Franco V; Florena AM; Ascani S; Paulli M; Salvato M; Pileri SA
    Histopathology; 2004 Apr; 44(4):381-6. PubMed ID: 15049905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marginal zone-related neoplasms of splenic and nodal origin.
    Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
    Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.
    Riccioni R; Caracciolo F; Galimberti S; Cecconi N; Petrini M
    Hematol Oncol; 2003 Dec; 21(4):163-8. PubMed ID: 14735554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcomes with and without splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ
    Am J Hematol; 2012 Nov; 87(11):E119-22. PubMed ID: 22887176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathologic features of splenic small B-cell lymphomas. A study of 42 cases with a definitive diagnosis by the World Health Organization classification.
    Kansal R; Ross CW; Singleton TP; Finn WG; Schnitzer B
    Am J Clin Pathol; 2003 Sep; 120(3):335-47. PubMed ID: 14502797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary splenic lymphoma: does it exist?
    Gobbi PG; Grignani GE; Pozzetti U; Bertoloni D; Pieresca C; Montagna G; Ascari E
    Haematologica; 1994; 79(3):286-93. PubMed ID: 7926983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study.
    Pich A; Fraire F; Fornari A; Bonino LD; Godio L; Bortolin P; Chiusa L; Palestro G
    Eur J Haematol; 2006 May; 76(5):392-8. PubMed ID: 16480431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-MALT marginal zone lymphoma.
    Thieblemont C; Davi F; Noguera ME; Brière J
    Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
    Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.